Agent for prophylaxis and treatment of angiostenosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/44 (2006.01) A61K 31/00 (2006.01) A61K 31/437 (2006.01) A61K 31/4409 (2006.01) A61K 31/445 (2006.01) A61P 9/00 (2006.01) C07D 213/75 (2006.01) C07D 213/81 (2006.01)

Patent

CA 2369552

Preventives/remedies for angiostenosis which contain compounds having an Rho kinase inhibitory activity. Compounds having an Rho kinase inhibitory activity such as (+)-trans-4-(1-aminoethyl)-1-(4-pyridylcarbamoyl)cyclohexane have various effects of suppressing the proliferation of endometrium regenerated after vascular lesion and the like. Owing to these effects, the above compounds are useful as preventives/remedies for angiostenosis, more particularly, angiostenosis induced by vascular wall lesion (for example, angiorestenosis following percutaneous coronary arterioplasty, angiorestenosis following percutaneous arterioplasty, angiostenosis following revascularization by indwelling a DCA or a stent, and angiostenosis following organ transplantation).

La présente invention concerne des compositions préventives/traitements contre l'angiosténose renfermant des composés ayant une activité inhibitrice de la Rho kinase. Les composés ayant une activité inhibitrice de la Rho kinase tels que (+)-trans-4- (1-aminoéthyl)-1-(4-pyridylcarbamoyl)cyclohexane présentent des effets variés de suppression de la prolifération de l'endomètre régénéré après une lésion vasculaire et analogue. Grâce à ses effets, les composés précités sont utilisés pour empêcher/traiter l'angiosténose, plus particulièrement, l'angiosténose induite par une lésion de paroi vasculaire (par exemple, l'angiosténose suite à une artérioplastie coronaire percutanée, l'angiosténose suite à une artérioplastie percutanée, l'angiosténose suite à une revascularisation par fixation à demeure d'un DCA ou d'un tuteur, et enfin, l'angiosténose suite à une transplantation d'organe).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Agent for prophylaxis and treatment of angiostenosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for prophylaxis and treatment of angiostenosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for prophylaxis and treatment of angiostenosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1800176

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.